Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma

समान संसाधन

• Epidermal growth factor receptor T790M mutation as a prognostic factor in EGFR-mutant non-small cell lung cancer patients that acquired resistance to EGFR tyrosine kinase inhibitors
  द्वारा: Ma, Guangzhi, और अन्य
  प्रकाशित: (2017)
• EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
  द्वारा: Chen, Yang, और अन्य
  प्रकाशित: (2018)
• Is T790M mutation the key in development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)?
  द्वारा: Takabe, Kazuaki
  प्रकाशित: (2011)
• Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
  द्वारा: Lee, Sang Hoon, और अन्य
  प्रकाशित: (2020)
• A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma
  द्वारा: Fawwaz, Muammar, और अन्य
  प्रकाशित: (2021)